Forefront Wealth Management Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Forefront Wealth Management Inc.

$114 Million
Q2 2025

A detailed history of Forefront Wealth Management Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Forefront Wealth Management Inc. holds 3,020 shares of REGN stock, worth $1.81 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares

3,020

Previous 3,121 3.24%

Holding current value

$1.81 Million

Previous $1.98 Million 19.91%

% of portfolio

1.39%

Previous 2.06%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 17, 2025	SELL	$483.07 - $625.6 $48,790 - $63,185	-101 Reduced 3.24%	3,020 $1.59 Million
Q1 2025 Apr 17, 2025	BUY	$634.14 - $744.83 $15,219 - $17,875	24 Added 0.77%	3,121 $1.98 Million
Q4 2024 Feb 11, 2025	SELL	$701.85 - $1046.91 $4,912 - $7,328	-7 Reduced 0.23%	3,097 $2.21 Million
Q3 2023 Nov 06, 2023	BUY	$692.45 - $844.37 $2,077 - $2,533	3 Added 0.1%	3,104 $2.55 Million
Q2 2023 Aug 07, 2023	SELL	$700.03 - $830.35 $17,500 - $20,758	-25 Reduced 0.8%	3,101 $2.23 Million
Q1 2023 May 09, 2023	SELL	$680.49 - $826.97 $1.36 Million - $1.66 Million	-2,003 Reduced 39.05%	3,126 $2.57 Million
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $27,529 - $29,889	-39 Reduced 0.75%	5,129 $3.7 Million
Q3 2022 Nov 01, 2022	SELL	$573.97 - $724.32 $64,284 - $81,123	-112 Reduced 2.12%	5,168 $3.56 Million
Q2 2022 Jul 28, 2022	BUY	$548.35 - $738.84 $122,282 - $164,761	223 Added 4.41%	5,280 $3.13 Million
Q1 2022 May 09, 2022	SELL	$595.12 - $698.43 $14,282 - $16,762	-24 Reduced 0.47%	5,057 $3.53 Million
Q4 2021 Feb 04, 2022	BUY	$543.48 - $670.97 $2.76 Million - $3.41 Million	5,081 New	5,081 $3.21 Million

Others Institutions Holding REGN

# of Institutions

1,421

Shares Held

88.7M

Call Options Held

1.98M

Put Options Held

1.75M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $64.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forefront Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Forefront Wealth Management Inc. with notifications on news.

Account

Forefront Wealth Management Inc. Regeneron Pharmaceuticals, Inc. Transaction History